Morepen Laboratories Other Announcement
Morepen filed its Q2FY27 Monitoring Agency Report confirming Nil deviation in QIP proceeds utilization. The company spent ₹1.12 crore on modernization and expansion during the quarter.
ALFA Filings
Every announcement, straight from the exchange
Every Morepen Laboratories other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements
Morepen filed its Q2FY27 Monitoring Agency Report confirming Nil deviation in QIP proceeds utilization. The company spent ₹1.12 crore on modernization and expansion during the quarter.
Morepen Laboratories Ltd has filed its shareholding pattern for the quarter ended September 30, 2026, in compliance with regulatory requirements.
Morepen Laboratories has been assigned an 'Adequate' ESG rating of 'CRISIL ESG 60' by Crisil ESG Ratings & Analytics Limited based on publicly disclosed information.
Morepen Laboratories' Monitoring Agency Report for Q1 FY27 confirms usage of QIP proceeds. The company faces a GST show-cause notice of ₹117.94 crore.
Morepen Laboratories' wholly owned subsidiary, Morepen Labs - FZCO, changed its name to Morepen Labs FZE following migration from IFZA to JAFZA, Dubai.
Morepen Laboratories submitted its Annual Secretarial Compliance Report for the financial year ended March 2026. The report notes unresolved observations regarding share cancellation and listing alignment.